Vanguard Group’s Aethlon Medical AEMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53
| Closed | -$7.6K | – | 4275 |
|
|
2025
Q1 | $7.6K | Hold |
53
| – | – | ﹤0.01% | 4262 |
|
|
2024
Q4 | $18.3K | Hold |
53
| – | – | ﹤0.01% | 4263 |
|
|
2024
Q3 | $9.89K | Hold |
53
| – | – | ﹤0.01% | 4324 |
|
|
2024
Q2 | $10.6K | Hold |
53
| – | – | ﹤0.01% | 4389 |
|
|
2024
Q1 | $35.7K | Hold |
53
| – | – | ﹤0.01% | 4348 |
|
|
2023
Q4 | $46.5K | Buy |
53
+5
| +10% | +$3.56K | ﹤0.01% | 4379 |
|
|
2023
Q3 | $43K | Sell |
48
-2
| -4% | -$2.57K | ﹤0.01% | 4426 |
|
|
2023
Q2 | $71.3K | Hold |
50
| – | – | ﹤0.01% | 4420 |
|
|
2023
Q1 | $75.8K | Sell |
50
-1
| -2% | -$1.88K | ﹤0.01% | 4426 |
|
|
2022
Q4 | $56.2K | Sell |
51
-212
| -81% | -$386K | ﹤0.01% | 4435 |
|
|
2022
Q3 | $613K | Buy |
263
+139
| +112% | +$601K | ﹤0.01% | 4160 |
|
|
2022
Q2 | $554K | Hold |
124
| – | – | ﹤0.01% | 4265 |
|
|
2022
Q1 | $722K | Sell |
124
-12
| -9% | -$71.6K | ﹤0.01% | 4301 |
|
|
2021
Q4 | $1.01M | Sell |
136
-8
| -6% | -$91.1K | ﹤0.01% | 4263 |
|
|
2021
Q3 | $2.23M | Sell |
144
-1
| -0.7% | -$16.8K | ﹤0.01% | 4032 |
|
|
2021
Q2 | $2.85M | Buy |
145
+102
| +237% | +$1.17M | ﹤0.01% | 3853 |
|
|
2021
Q1 | $347K | Hold |
43
| – | – | ﹤0.01% | 4189 |
|
|
2020
Q4 | $423K | Buy |
43
+12
| +39% | +$80.2K | ﹤0.01% | 3983 |
|
|
2020
Q3 | $165K | Hold |
31
| – | – | ﹤0.01% | 3970 |
|
|
2020
Q2 | $249K | Hold |
31
| – | – | ﹤0.01% | 3894 |
|
|
2020
Q1 | $186K | Buy |
31
+28
| +933% | +$237K | ﹤0.01% | 3871 |
|
|
2019
Q4 | $13K | Sell |
3
-1
| -25% | -$12K | ﹤0.01% | 4107 |
|
|
2019
Q3 | $53K | Sell |
4
-3
| -43% | -$52K | ﹤0.01% | 4081 |
|
|
2019
Q2 | $147K | Hold |
7
| – | – | ﹤0.01% | 4013 |
|
|
2019
Q1 | $404K | Hold |
7
| – | – | ﹤0.01% | 3811 |
|
|
2018
Q4 | $684K | Sell |
7
-2
| -22% | -$145K | ﹤0.01% | 3665 |
|
|
2018
Q3 | $636K | Hold |
9
| – | – | ﹤0.01% | 3809 |
|
|
2018
Q2 | $689K | Hold |
9
| – | – | ﹤0.01% | 3776 |
|
|
2018
Q1 | $633K | Buy |
9
+2
| +29% | +$177K | ﹤0.01% | 3742 |
|
|
2017
Q4 | $501K | Buy |
7
+3
| +75% | +$183K | ﹤0.01% | 3749 |
|
|
2017
Q3 | $331K | Buy |
4
+3
| +300% | +$323K | ﹤0.01% | 3823 |
|
|
2017
Q2 | $157K | Sell |
1
-1
| -50% | -$129K | ﹤0.01% | 3936 |
|
|
2017
Q1 | $310K | Hold |
2
| – | – | ﹤0.01% | 3833 |
|
|
2016
Q4 | $398K | Buy |
2
+1
| +100% | +$280K | ﹤0.01% | 3774 |
|
|
2016
Q3 | $429K | Hold |
1
| – | – | ﹤0.01% | 3786 |
|
|
2016
Q2 | $406K | Hold |
1
| – | – | ﹤0.01% | 3825 |
|
|
2016
Q1 | $389K | Hold |
1
| – | – | ﹤0.01% | 3842 |
|
|
2015
Q4 | $470K | Hold |
1
| – | – | ﹤0.01% | 3849 |
|
|
2015
Q3 | $283K | Buy |
+1
| New | +$504K | ﹤0.01% | 3975 |
|
Other funds holding AEMD
AC
IC
BFM
TRCT
Vanguard Group's AEMD Position: Q2 2025 in Review
Vanguard Group sold out of Aethlon Medical (AEMD) in Q2 2025, closing a stake of 53 shares — an estimated $7.6K sold.
Vanguard Group first reported a position in AEMD in Q3 2015 and held it in 39 quarters. The position peaked at $2.85M in Q2 2021. 12 funds tracked by Wall St. Rank hold AEMD as of Q2 2025.
- Vanguard Group reported no remaining Aethlon Medical position as of Q2 2025 after selling out during the quarter.
- Vanguard Group sold 53 Aethlon Medical shares in Q2 2025, an estimated $7.6K.
- Vanguard Group first reported a position in Aethlon Medical in Q3 2015 and held it in 39 quarters.
- Vanguard Group's Aethlon Medical position peaked at $2.85M in Q2 2021.
- 12 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2025.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.